Clinical trial Recruiting at 1 site Interventional Ages 14 to 26

Real-time engagement app to improve glycemic control in adolescents and young adults with type 2 diabetes

Official title: Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Run by University of Pittsburgh · NCT06375460 · Data updated 2026-11-12

A smartphone app that combines glucose, activity, and diet data is tested to see if it helps teens and young adults with type 2 diabetes manage their blood sugar better.

More Diabetes Mellitus, Type 2 trials

Quick facts

Study typeInterventional
Ages14 Years to 26 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedSeptember 20, 2026
Main results expectedJuly 2029
Study endsAugust 2029
Registry record updatedOctober 7, 2026
Trial IDNCT06375460 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents and young adults with type 2 diabetes who speak English and do not have autoantibody-positive diabetes or monogenic diabetes suspicion.

Probably not a fit

Individuals with current pregnancy, cognitive or severe psychiatric conditions, eating disorders, or hydroxyurea use may not experience benefit or may be excluded from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

REFLECT2D tests whether real-time, linked glucose and health-behavior data via a mobile app can improve glycemic control in adolescents and young adults with type 2 diabetes. After an education session and run-in, participants undergo a 90-day micro-randomized trial assigning them to a daily prompt focused on physical activity, a prompt focused on diet, or no prompt, followed by a 90-day observation period. Participants wear a continuous glucose monitor and a fitness tracker, use the app for 6 months, and provide occasional dietary logs and in-person visits with fasting blood draws. The study evaluates short- and longer-term changes in glycemic control and the persistence of these changes after prompts end.

Why it matters

Potential benefit: If successful, the app could help users better interpret glycemic data and sustain healthier behaviors to improve blood sugar control.

How similar studies have gone: Prior studies in diabetes behavior interventions suggest that real-time data feedback can support behavior change, but this specific MRT-based digital approach in youth-onset type 2 diabetes is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes
* English-speaking (app in English)

Exclusion Criteria:

* Current pregnancy
* Hydroxyurea use (CGM sensor inaccuracies)
* Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management
* Current or previously diagnosed eating disorder

Where it's running

  • UPMC Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Mary Ellen Vajravelu, MD — University of Pittsburgh
  • Study coordinator: Mary Ellen Vajravelu, MD
  • Email: vajravelume@upmc.edu
  • Phone: 412-692-6533

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.